Oral submucosal fibrosis

0
Oral submucosal fibrosis

Oral submucosal fibrosis (OSF) is a chronic, progressive disorder characterized by fibrosis and contraction of the oral mucosa, resulting in limited tissue mobility, especially of the tongue and other oral structures. This condition primarily occurs in people who consume betel-containing products such as chewing tobacco or betel nuts. OSF causes significant changes in the mucosa over time, which are accompanied by clinical manifestations such as pain, discomfort, difficulty swallowing, and loss of taste. In severe cases, oral cancer may develop, so this disorder requires careful monitoring and early diagnosis to prevent serious complications.

History of the disease and interesting historical facts

The history of oral submucous fibrosis goes back to ancient times, when various cultures began to use chewable preparations containing betel quid to improve mood, social activity, and as a traditional remedy. OSF was first described in 1952 by an Indian physician who noted a link between betel chewing and the development of this pathology. Research conducted over the following decades showed that the disease is predominantly prevalent among the population of South and Southeast Asia, which is associated with the cultural and gastronomic habits of these regions. An interesting fact is that, despite the availability of information about the harm of betel, many cultures continue to consume it, which leads to a high risk of OSF. Moreover, the population using betel quid is often unaware of the dangers of this action, which makes the study and dissemination of knowledge about OSF especially relevant.

Epidemiology

The epidemiology of oral submucosal fibrosis shows high incidence rates, especially in Southeast Asian countries such as India, Bangladesh, Pakistan and Sri Lanka. Overall, the prevalence of OSF among betel chewers ranges from 0.5% to 17% in different populations. In some regions of the above-mentioned countries, this condition may affect up to 33% of the population in certain groups. Studies show that OSF is more common in men than in women, especially in the age group of 30 to 50 years. Lifestyle changes and health interventions such as eating fresh vegetables and fruits and avoiding unhealthy habits can reduce the risk of developing the disease.

Genetic predisposition to this disease

Genetic predisposition to oral submucous fibrosis remains the subject of intensive research. Several genes have been identified that may increase the risk of developing this disease, including genes associated with inflammatory processes and carcinogen metabolism. For example, mutations in the CYP1A1 and GSTM1 genes may contribute to inadequate metabolism of toxic substances contained in betel quid. In parallel, other factors besides genetic ones are being studied, such as gene polymorphisms that affect individual sensitivity to carcinogens, which may also play a role in the pathogenesis of OSF.

Risk factors for the development of this disease

There are several known risk factors that contribute to the development of oral submucosal fibrosis, which can be classified into physical and chemical. The main risk factors include:

  • Betel quid and chewing tobacco consumption are the most significant factors associated with the progression of OSF.
  • Smoking – increases the risk of oral diseases and may contribute to the development of OSF.
  • Malnutrition – Deficiencies in certain vitamins and minerals, such as vitamin B12 and iron, can worsen the condition.
  • Environmental pollution influences – local pollution and exposure to carcinogens may contribute to the development of the disease.
  • Racial and ethnic characteristics – certain groups of the population have a higher risk than others, which may be due to cultural factors.

Diagnosis of this disease

Diagnosis of oral submucosal fibrosis is based on clinical symptoms, physical examination, and ancillary testing. Key symptoms include:

  • Limited mobility of the tongue.
  • Constant pain and discomfort in the mouth area.
  • Dry mouth and changes in the mucous membrane.
  • Dysphagia (difficulty swallowing).

Laboratory tests may be used to exclude other oral diseases and systemic pathologies. Radiological examinations such as X-rays and CT scans may show tissue changes. Differential diagnosis is important, it is important to exclude oral cancer, leukoplakia and other precancerous conditions.

Treatment

Treatment of oral submucous fibrosis is varied and includes both conservative and surgical methods. The main approaches to treatment are:

  • General treatment includes lifestyle changes, avoidance of chewing tobacco and betel quid.
  • Pharmacological treatment may include the use of vitamins, anti-inflammatory and antioxidant agents.
  • Surgical treatment is indicated in cases of severe deformation and dysfunction of the oral cavity.
  • Other treatments may include physical therapy and local analgesics to reduce pain.

List of medications used to treat this disease

Medications used to treat oral submucosal fibrosis include:

  • Steroids (prednisolone) to reduce inflammation.
  • B vitamins to improve metabolism.
  • Anti-inflammatory drugs (ibuprofen).
  • Antioxidants (vitamin E).
  • Local analgesics to reduce pain.

Disease monitoring

Monitoring of oral submucosal fibrosis includes regular physician examinations, mucosal assessments, and functional tests of tongue and oral motility. The prognosis of the disease varies, but if untreated, OSF can lead to serious complications, including oral cancer, highlighting the importance of early detection and intervention. Complications can include difficulty swallowing, nutritional problems, and, in more advanced cases, profound tissue changes.

Age-related features of the disease

Oral submucosal fibrosis is more common in adults, especially those between the ages of 30 and 50, but can also occur in younger people. However, the disease may be more aggressive in older people, possibly due to the combination of other chronic diseases and decreased immune function. OSF is rare in children, but prevention and early diagnosis are important if they have symptoms associated with chewing tobacco.

Questions and Answers

  • What is oral submucosal fibrosis? It is a chronic disease characterized by fibrosis of the oral mucosa, which can lead to limited tongue mobility and pain.
  • What are the main risk factors for OSF? Major risk factors include betel quid and chewing tobacco use, smoking, vitamin deficiency and environmental pollution.
  • How is OSF diagnosed? Diagnosis is based on clinical symptoms, physical examination and ancillary methods such as laboratory and radiological studies.
  • What treatment methods are used? Treatment can range from conservative methods such as lifestyle changes and medications to surgical interventions to correct deformities.
  • What is the prognosis for patients with OSF? The prognosis for the disease varies, but if left untreated, OSF can lead to serious complications, including oral cancer, making early diagnosis critical.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.